AURO-RAMIPRIL TABLETS 1.25 ramipril 1.25mg tablet blister pack

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

ramipril, Quantity: 1.25 mg

Доступно од:

Arrotex Pharmaceuticals Pty Ltd

INN (Међународно име):

Ramipril

Фармацеутски облик:

Tablet, uncoated

Састав:

Excipient Ingredients: lactose monohydrate; pregelatinised maize starch; sodium stearylfumarate; croscarmellose sodium; sodium bicarbonate

Пут администрације:

Oral

Јединице у пакету:

28, 30

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

? Treatment of hypertension. Data are currently not available to support the use of Ramipril in renovascular hypertension. ,? Post MI heart failure ,? Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularization procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160mmHg or diastolic blood pressure >90mmHg (or on antihypertensive treatment); total cholesterol >5.2mmol/L; HDL cholesterol <0.9mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease.

Резиме производа:

Visual Identification: White to off-white coloured, flat faced bevel edged round uncoated tablet debossed with 'H' &'17' on one side and plain on other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Статус ауторизације:

Licence status A

Датум одобрења:

2011-10-06